These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 27219534)
1. The microglial ATP-gated ion channel P2X7 as a CNS drug target. Bhattacharya A; Biber K Glia; 2016 Oct; 64(10):1772-87. PubMed ID: 27219534 [TBL] [Abstract][Full Text] [Related]
2. The evolution of P2X7 antagonists with a focus on CNS indications. Rech JC; Bhattacharya A; Letavic MA; Savall BM Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304 [TBL] [Abstract][Full Text] [Related]
3. A central role for P2X7 receptors in human microglia. Janks L; Sharma CVR; Egan TM J Neuroinflammation; 2018 Nov; 15(1):325. PubMed ID: 30463629 [TBL] [Abstract][Full Text] [Related]
4. Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia. Bhattacharya A; Lord B; Grigoleit JS; He Y; Fraser I; Campbell SN; Taylor N; Aluisio L; O'Connor JC; Papp M; Chrovian C; Carruthers N; Lovenberg TW; Letavic MA Neuropsychopharmacology; 2018 Dec; 43(13):2586-2596. PubMed ID: 30026598 [TBL] [Abstract][Full Text] [Related]
5. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases. Illes P Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423 [TBL] [Abstract][Full Text] [Related]
6. The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia. Kim EA; Cho CH; Kim J; Hahn HG; Choi SY; Yang SJ; Cho SW Neurotoxicology; 2015 Dec; 51():198-206. PubMed ID: 26522449 [TBL] [Abstract][Full Text] [Related]
7. Ion channels on microglia: therapeutic targets for neuroprotection. Skaper SD CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139 [TBL] [Abstract][Full Text] [Related]
8. Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders. Bhattacharya A Front Pharmacol; 2018; 9():30. PubMed ID: 29449810 [TBL] [Abstract][Full Text] [Related]
9. Leveraging the ATP-P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications. Yin Y; Wei L; Caseley EA; Lopez-Charcas O; Wei Y; Li D; Muench SP; Roger S; Wang L; Jiang LH Med Res Rev; 2023 Sep; 43(5):1346-1373. PubMed ID: 36924449 [TBL] [Abstract][Full Text] [Related]
10. P2X7 antagonists as potential therapeutic agents for the treatment of CNS disorders. Chrovian CC; Rech JC; Bhattacharya A; Letavic MA Prog Med Chem; 2014; 53():65-100. PubMed ID: 24418608 [TBL] [Abstract][Full Text] [Related]
11. Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. Bhattacharya A; Jones DNC Psychoneuroendocrinology; 2018 Dec; 98():95-100. PubMed ID: 30121550 [TBL] [Abstract][Full Text] [Related]
12. A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334. Lord B; Ameriks MK; Wang Q; Fourgeaud L; Vliegen M; Verluyten W; Haspeslagh P; Carruthers NI; Lovenberg TW; Bonaventure P; Letavic MA; Bhattacharya A Eur J Pharmacol; 2015 Oct; 765():551-9. PubMed ID: 26386289 [TBL] [Abstract][Full Text] [Related]
13. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. Wei L; Syed Mortadza SA; Yan J; Zhang L; Wang L; Yin Y; Li C; Chalon S; Emond P; Belzung C; Li D; Lu C; Roger S; Jiang LH Neurosci Biobehav Rev; 2018 Apr; 87():192-205. PubMed ID: 29453990 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432. Lord B; Aluisio L; Shoblock JR; Neff RA; Varlinskaya EI; Ceusters M; Lovenberg TW; Carruthers N; Bonaventure P; Letavic MA; Deak T; Drinkenburg W; Bhattacharya A J Pharmacol Exp Ther; 2014 Dec; 351(3):628-41. PubMed ID: 25271258 [TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody. Kaczmarek-Hajek K; Zhang J; Kopp R; Grosche A; Rissiek B; Saul A; Bruzzone S; Engel T; Jooss T; Krautloher A; Schuster S; Magnus T; Stadelmann C; Sirko S; Koch-Nolte F; Eulenburg V; Nicke A Elife; 2018 Aug; 7():. PubMed ID: 30074479 [TBL] [Abstract][Full Text] [Related]
16. Extracellular ATP enhances radiation-induced brain injury through microglial activation and paracrine signaling via P2X7 receptor. Xu P; Xu Y; Hu B; Wang J; Pan R; Murugan M; Wu LJ; Tang Y Brain Behav Immun; 2015 Nov; 50():87-100. PubMed ID: 26122280 [TBL] [Abstract][Full Text] [Related]
17. P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia. Shieh CH; Heinrich A; Serchov T; van Calker D; Biber K Glia; 2014 Apr; 62(4):592-607. PubMed ID: 24470356 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of the brain P2X7 ion channel attenuates repeated social defeat induced microglia reactivity, monocyte recruitment and anxiety-like behavior in male mice. Biltz RG; Swanson SP; Draime N; Davis AC; Yin W; Goodman EJ; Gallagher NR; Bhattacharya A; Sheridan JF; Godbout JP Brain Behav Immun; 2024 Jan; 115():356-373. PubMed ID: 37914101 [TBL] [Abstract][Full Text] [Related]
19. Interactions of pannexin 1 with NMDA and P2X7 receptors in central nervous system pathologies: Possible role on chronic pain. Bravo D; Maturana CJ; Pelissier T; Hernández A; Constandil L Pharmacol Res; 2015 Nov; 101():86-93. PubMed ID: 26211949 [TBL] [Abstract][Full Text] [Related]
20. Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis. Sidoryk-Węgrzynowicz M; Strużyńska L Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]